Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 26;20(1):421.
doi: 10.1186/s12936-021-03955-0.

Network-driven analysis of human-Plasmodium falciparum interactome: processes for malaria drug discovery and extracting in silico targets

Affiliations

Network-driven analysis of human-Plasmodium falciparum interactome: processes for malaria drug discovery and extracting in silico targets

Francis E Agamah et al. Malar J. .

Abstract

Background: The emergence and spread of malaria drug resistance have resulted in the need to understand disease mechanisms and importantly identify essential targets and potential drug candidates. Malaria infection involves the complex interaction between the host and pathogen, thus, functional interactions between human and Plasmodium falciparum is essential to obtain a holistic view of the genetic architecture of malaria. Several functional interaction studies have extended the understanding of malaria disease and integrating such datasets would provide further insights towards understanding drug resistance and/or genetic resistance/susceptibility, disease pathogenesis, and drug discovery.

Methods: This study curated and analysed data including pathogen and host selective genes, host and pathogen protein sequence data, protein-protein interaction datasets, and drug data from literature and databases to perform human-host and P. falciparum network-based analysis. An integrative computational framework is presented that was developed and found to be reasonably accurate based on various evaluations, applications, and experimental evidence of outputs produced, from data-driven analysis.

Results: This approach revealed 8 hub protein targets essential for parasite and human host-directed malaria drug therapy. In a semantic similarity approach, 26 potential repurposable drugs involved in regulating host immune response to inflammatory-driven disorders and/or inhibiting residual malaria infection that can be appropriated for malaria treatment. Further analysis of host-pathogen network shortest paths enabled the prediction of immune-related biological processes and pathways subverted by P. falciparum to increase its within-host survival.

Conclusions: Host-pathogen network analysis reveals potential drug targets and biological processes and pathways subverted by P. falciparum to enhance its within malaria host survival. The results presented have implications for drug discovery and will inform experimental studies.

Keywords: Drug resistance; Gene ontology; Genomics; Malaria; Multi-omics; Protein–protein interaction.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Therefore, the authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
An overview of the approach implemented in this study
Fig. 2
Fig. 2
A Assembled parasite network and B Functional interactions between C6KTD2 and C6KTB7 subnetwork within the parasite network. The nodes common to the subnetworks are coloured in yellow
Fig. 3
Fig. 3
A Different distributions of disease similarity scores obtained in terms of frequencies (proportions) of disease matches vs similarity scores between disease-associated processes. The bigger rectangular bar indicates the threshold for the similarity between disease pairs of which the enriched similarity score (ESS) were used for further analysis. B Distributions of drug similarity scores obtained in terms of the relative frequency of drug matches against functional similarity scores between candidate gene and drug. The bigger rectangular bar indicates the threshold for the similarity between drug pairs of which the enriched similarity score (ESS) were used for further analysis
Fig. 4
Fig. 4
A Functional interactions between C6KTD2 and C6KTB7 subnetwork in the unified host–pathogen functional network. The shared host proteins (yellow nodes) are involved in protein ubiquitination, positive regulation of cell apoptotic process, signal transduction, regulatory processes, and histone methylation. B Predicted shortest path network that could influence resistance and parasite adaptiveness between C6KTB7 (green node) and O00206 (bottom sky blue node) via co–targets (central sky blue nodes) in the host–pathogen network. C Predicted shortest path network that could influence resistance and parasite adaptiveness between C6KTD2 (green node) and O00206 (bottom sky blue node) via mediators (central sky blue nodes) in the host–pathogen network
Fig. 4
Fig. 4
A Functional interactions between C6KTD2 and C6KTB7 subnetwork in the unified host–pathogen functional network. The shared host proteins (yellow nodes) are involved in protein ubiquitination, positive regulation of cell apoptotic process, signal transduction, regulatory processes, and histone methylation. B Predicted shortest path network that could influence resistance and parasite adaptiveness between C6KTB7 (green node) and O00206 (bottom sky blue node) via co–targets (central sky blue nodes) in the host–pathogen network. C Predicted shortest path network that could influence resistance and parasite adaptiveness between C6KTD2 (green node) and O00206 (bottom sky blue node) via mediators (central sky blue nodes) in the host–pathogen network

References

    1. WHO. World malaria report 2019. Geneva, World Health Organization, 2019.
    1. Takala-Harrison S, Laufer MK. Antimalarial drug resistance in Africa: key lessons for the future. Ann N Y Acad Sci. 2015;1342:62–67. doi: 10.1111/nyas.12766. - DOI - PMC - PubMed
    1. Amor A, Toro C, Fernandez-Martinez A, Baquero M, Benito A, Berzosa P. Molecular markers in Plasmodium falciparum linked to resistance to anti-malarial drugs in samples imported from Africa over an eight-year period (2002–2010): impact of the introduction of artemisinin combination therapy. Malar J. 2012;11:100. doi: 10.1186/1475-2875-11-100. - DOI - PMC - PubMed
    1. Ouji M, Augereau J-M, Paloque L, Benoit-Vical F. Plasmodium falciparum resistance to artemisinin-based combination therapies: a sword of Damocles in the path toward malaria elimination. Parasite. 2018;25:24. doi: 10.1051/parasite/2018021. - DOI - PMC - PubMed
    1. Miraclin TA, Matthew A, Rupali P. Decreased response to artemisinin combination therapy in falciparum malaria: a preliminary report from South India. Trop Parasitol. 2016;6:85–86. doi: 10.4103/2229-5070.175125. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources